PCSA
Processa Pharmaceuticals Inc
Halal Rating :
Last Price
$0.81
Last updated:
Market Cap
-
7D Change
-2.36%
1 Year Change
-67.65%
Company Overview
Industries
Exchange
Next Earnings Date
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs intended to improve the survival and/or quality of life for patients who have unmet medical needs. The company is developing next-generation chemotherapy drugs that have demonstrated improved safety and efficacy over existing treatments.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Processa Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.